November 13, 2023 Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum read more
October 3, 2023 Ultrasensitive immunoassay technology drives blood-based biomarkers for Alzheimer’s disease read more
September 6, 2023 Serum neurofilament light chain database effective in estimating pediatric neuro issues read more
July 18, 2023 Quanterix To Provide Research Use Access to the p217+tau Assay Through Quanterix Accelerator Services Laboratory read more
November 28, 2023 Going Beyond Cerebrospinal Fluid (CSF) Biomarkers for Alzheimer’s Disease read more
November 16, 2023 Utilizing Digital ELISA for Precise Measurement of Brain Biomarkers in Blood read more